Co-Founder & Chief Executive Officer
Constantine Theodoropulos co-founded GO Therapeutics in 2014 with the mission to leverage the biology of cancer glycoproteins to create new and powerful cancer therapies.
Constantine has successful track record as an entrepreneur and advisor to companies on the forefront of life sciences and technology. Prior to GO, Constantine was founder and president of Base Pair Group, a strategic consultancy assisting life science companies on strategy, marketing and business development. He also was a key executive for EBD Group, the leading life science partnering events firm, where he played a key role in EBD’s evolution into the dominant firm facilitating partnering for life science companies, with events generating more than 50,000 partnering meetings each year across three continents.
Earlier, he founded Boston Communications, a boutique strategic marketing agency and grew the company into one of the top-rated independent strategic communications agencies serving high technology markets internationally. Mr. Theodoropulos is a frequent advisor to senior executives, boards of directors and venture capitalists. He also raised critical funds and awareness for Dana-Farber Cancer Institute’s Center for Adolescent and Young Adult Oncology in its early stages.